About This Opportunity National Imaging Facility based at the Australian Institute for Bioengineering and Nanotechnology (AIBN) is a full‑time (100%) fixed‑term position at Academic Level E, lasting up to five years. The role combines the responsibilities of NIF‑Q Director and AIBN Group Leader within a research‑intensive environment at AIBN. The incumbent will establish leadership in discovery and translational research programs in radiotheranostics, build critical mass in novel programmes that exploit world‑class molecular imaging and radiopharmaceutical capabilities, and oversee delivery of the NIF‑Q Facility. The position offers opportunities to engage with the broader imaging ecosystem at UQ, link to translational clinical research at Herston Imaging Research Facility (HIRF), and strengthen international recognition across academia, industry and government. Key Responsibilities Research Establish a leading research program. Collaborate on research projects. Seek and manage research funding. Publish in reputable journals. Utilise best practice research methodologies. Participate in project discussions. Teaching Achieve teaching quality as indicated by approved surveys and student outcomes. Improve or innovate teaching where appropriate in response to feedback. Supervision and Researcher Development Supervise students. Recruit and manage employees related to NIF‑Q capability and research team. Provide performance feedback and training. Resolve conflicts. Ensure correct remuneration and benefits. Citizenship and Service Develop partnerships. Demonstrate leadership through mentoring. Engage in internal service roles and committees. Perform administrative functions. Provide support to colleagues and uphold university values. Qualifications Extensive Academic and Industry Background – A PhD in life sciences with over 10 years of international experience across academia and/or industry. Nanotechnology Research Expertise – Proven track record in theranostics, especially in diagnostics, radiotherapies, theranostics and/or the role of the immune system in radiotherapy. Executive and Leadership Experience – Demonstrated leadership in nanobiotechnology, including technical and leadership skills. Commercialisation and IP Strategy – Strong understanding of IP portfolio management and commercialisation pathways for nano‑ and biotechnological products. Local Ecosystem Engagement – Thorough understanding of the Australian and Queensland imaging and biotechnology landscape, with a commitment to growing the ecosystem through UQ and NIF networks. Collaborative Track Record – History of successful collaboration with academic and industry partners, fostering productive external and internal relationships. Ethical and Research Integrity – Commitment to high standards of ethical conduct and research excellence. Advocacy and Representation – Ability to represent and promote nanobiotechnology initiatives at university, industry, and government levels. Organisational Management – Experience managing people, finances, and resources in dynamic research and service‑based environments. Benefits 26 weeks of paid parental leave. 17.5% annual leave loading. Flexible working arrangements, including hybrid on‑site/WFH options and flexible start/finish times. Genuine career progression opportunities via the academic promotions process. Access to world‑class facilities, grant writing support, research funding opportunities, and staff support and development. EEO Statement UQ is committed to a fair, equitable and inclusive selection process, which recognises that some applicants may face additional barriers and challenges which have impacted and/or continue to impact their career trajectory. Candidates who don’t meet all criteria are encouraged to apply and demonstrate their potential. J-18808-Ljbffr